首页 | 本学科首页   官方微博 | 高级检索  
     

抗肿瘤多核铂配合物的研究
引用本文:徐刚,姜平元,苟少华. 抗肿瘤多核铂配合物的研究[J]. 化学进展, 2012, 0(9): 1707-1719
作者姓名:徐刚  姜平元  苟少华
作者单位:1. 东南大学化学化工学院 南京 211189;2. 江苏省生物药物高技术研究重点实验室 南京 211189
基金项目:国家自然科学基金项目(No.20971022和No.21271041)资助
摘    要:多核铂配合物作为非经典铂抗肿瘤药物,其抗肿瘤机制与现有铂类抗肿瘤药物不同,因而在克服现有铂类抗肿瘤药物耐药性方面有着巨大的潜力。本文综述了多核铂类抗肿瘤药物的研究进展,以连接铂原子的桥配体结构的不同,可分为六大类:以烷基二胺及其衍生物为桥的多核铂配合物、以含氮杂环为桥的多核铂配合物、以羧酸根为桥的多核铂配合物、以卤素离子为桥的多核铂配合物、以含硫配体为桥的多核铂配合物及以其他配体为桥的多核铂配合物。本文还介绍了这几类多核铂配合物的抗肿瘤机理及在克服顺铂耐药性机理方面的研究进展。

关 键 词:多核铂  抗肿瘤活性  桥连基团  作用机理  DNA加合物  
收稿时间:2011-11-01
修稿时间:2012-06-01

Multinuclear Anticancer Platinum Complexes
Xu Gang,Jiang Pingyuan,Gou Shaohua. Multinuclear Anticancer Platinum Complexes[J]. Progress in Chemistry, 2012, 0(9): 1707-1719
Authors:Xu Gang  Jiang Pingyuan  Gou Shaohua
Affiliation:1. School of Chemistry and Chemical Engineering, Nanjing 211189, China;
2. Jiangsu Province Hi-Tech Key Laboratory for Bio-Medical Research, Nanjing 211189, China
Abstract:Multinuclear platinum anticancer complexes have been investigated intensively due to their novel structures and promising anticancer activities.Moreover,they are able to overcome cisplatin resistance because of their abilities to form different adducts with DNA compared with those formed by cisplatin.The research status of dinuclear and multinuclear anticancer platinum complexes is reviewed.Based on the different linking ligands,dinuclear and multinuclear are divided to six types,namely,alkyl diamines and their derivatives,heterocyclic compounds containing nitrogen atom(s),carboxylates,haloid anions,ligands containing sulfur atom(s) and other ligands.The possible anticancer mechanism and structure-activity relationship of these multinuclear platinum complexes are also discussed in this paper.
Keywords:multinuclear platinum complexes  anticancer activity  linking ligand  anticancer mechanism  DNA adduct
本文献已被 CNKI 等数据库收录!
点击此处可从《化学进展》浏览原始摘要信息
点击此处可从《化学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号